The University of Chicago Header Logo

Connection

Saara Kaviany to Humans

This is a "connection" page, showing publications Saara Kaviany has written about Humans.
Connection Strength

0.188
  1. Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations. Immunohorizons. 2024 07 01; 8(7):492-499.
    View in: PubMed
    Score: 0.030
  2. A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant. Pediatr Blood Cancer. 2024 Aug; 71(8):e31086.
    View in: PubMed
    Score: 0.030
  3. Curative Therapies for Sickle Cell Disease. Pediatr Ann. 2024 Feb; 53(2):e56-e61.
    View in: PubMed
    Score: 0.030
  4. Approach to Diagnosing Inborn Errors of Immunity. Rheum Dis Clin North Am. 2023 11; 49(4):731-739.
    View in: PubMed
    Score: 0.028
  5. Systems Immunology Analyses of STAT1 Gain-of-Function Immune Phenotypes Reveal Heterogeneous Response to IL-6 and Broad Immunometabolic Roles for STAT1. Immunohorizons. 2022 07 15; 6(7):447-464.
    View in: PubMed
    Score: 0.026
  6. The role of biomarkers in risk stratification, treatment and outcome in acute GVHD. Curr Opin Hematol. 2021 11 01; 28(6):401-407.
    View in: PubMed
    Score: 0.025
  7. Outcomes of pediatric patients with therapy-related myeloid neoplasms. Bone Marrow Transplant. 2021 12; 56(12):2997-3007.
    View in: PubMed
    Score: 0.006
  8. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function. Blood. 2021 05 06; 137(18):2450-2462.
    View in: PubMed
    Score: 0.006
  9. BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use. Lab Med. 2019 Oct 10; 50(4):401-405.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.